Nantahala Capital Management - ADC THERAPEUTICS SA ownership

Quarter-by-quarter ownership
Nantahala Capital Management ownership history of ADC THERAPEUTICS SA
ValueSharesWeighting
Q3 2023$230,674
-87.2%
257,162
-69.4%
0.02%
-88.6%
Q2 2023$1,806,000
+10.3%
840,0000.0%0.18%
+38.9%
Q1 2023$1,638,000
+75.3%
840,000
+245.3%
0.13%
+106.6%
Q4 2022$934,234243,2900.06%
Other shareholders
ADC THERAPEUTICS SA shareholders Q4 2023
NameSharesValueWeighting ↓
Vantage Consulting Group Inc 1,680,149$40,911,0007.12%
Grosvenor Holdings, L.L.C. 1,517,212$36,944,0003.67%
Burrage Capital Management LLC 124,875$3,041,0003.05%
Redmile Group, LLC 7,522,029$183,161,0002.71%
Indie Asset Partners, LLC 91,641$2,231,0001.81%
MPM BioImpact LLC 218,027$5,309,0000.87%
Ikarian Capital, LLC 300,000$7,305,0000.59%
Eventide Asset Management 1,311,990$31,948,0000.43%
Virtus ETF Advisers LLC 21,540$524,0000.22%
AlphaCentric Advisors LLC 26,000$633,0000.17%
View complete list of ADC THERAPEUTICS SA shareholders